Atrial‐like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial‐selective pharmacology

Abstract Drugs targeting atrial‐specific ion channels, Kv1.5 or Kir3.1/3.4, are being developed as new therapeutic strategies for atrial fibrillation. However, current preclinical studies carried out in non‐cardiac cell lines or animal models may not accurately represent the physiology of a human ca...

Descripció completa

Dades bibliogràfiques

Autors principals:	Harsha D Devalla, Verena Schwach, John W Ford, James T Milnes, Said El‐Haou, Claire Jackson, Konstantinos Gkatzis, David A Elliott, Susana M Chuva de Sousa Lopes, Christine L Mummery, Arie O Verkerk, Robert Passier
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer Nature 2015-02-01
Col·lecció:	EMBO Molecular Medicine
Matèries:	arrhythmias atrial cardiomyocytes atrial fibrillation COUP‐TF ion channels
Accés en línia:	https://doi.org/10.15252/emmm.201404757
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!